Rechavi G, Katzir N, Brok-Simoni F, Holtzman F, Mandel M, Gurfinkel N, Givol D, Ben-Bassat I, Ramot B
Institute of Hematology, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Leukemia. 1989 Jan;3(1):57-60.
Three cellular or putative oncogenes: c-myc, bcl1, and bcl2 were previously found to be rearranged in some B cell malignancies due to chromosomal translocations. Data concerning the role of such genetic rearrangements in B-CLL are very scanty and limited to few cases in which bcl1 rearrangements were found. We studied DNA samples from 38 cases of B-CLL by Southern blot technique in order to find out the existence and frequency of such events. No bcl1 or bcl2 rearrangements were found in any of the studied cases; thus, involvement of these genes in CLL must be rare. In one patient who had an aggressive and resistant disease, c-myc rearrangement was found.
c-myc、bcl1和bcl2,由于染色体易位,在一些B细胞恶性肿瘤中发生重排。关于此类基因重排在B细胞慢性淋巴细胞白血病(B-CLL)中的作用的数据非常稀少,且仅限于少数发现bcl1重排的病例。我们采用Southern印迹技术研究了38例B-CLL患者的DNA样本,以查明此类事件的存在情况和发生频率。在所研究的任何病例中均未发现bcl1或bcl2重排;因此,这些基因参与CLL的情况肯定很少见。在一名患有侵袭性和难治性疾病的患者中,发现了c-myc重排。